Loading...
Comprehensive Molecular Characterization and Response to Therapy in FH-Deficient Renal Cell Carcinoma
PURPOSE: Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a rare, aggressive form of RCC associated with hereditary leiomyomatosis and RCC syndrome (HLRCC). Evidence for systemic therapy efficacy is lacking. METHODS: We studied clinical and genomic characteristics of FH-RCC, including r...
Na minha lista:
| Udgivet i: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8127353/ https://ncbi.nlm.nih.gov/pubmed/33658299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-4367 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|